2023 American Heart Association Focused Update on the Management of Patients With Cardiac Arrest or Life-Threatening Toxicity Due to Poisoning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. | Canada Hyperbarics
Clinical Guideline Circulation 2023

2023 American Heart Association Focused Update on the Management of Patients With Cardiac Arrest or Life-Threatening Toxicity Due to Poisoning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

Lavonas EJ, Akpunonu PD, Arens AM, Babu KM, Cao D, Hoffman RS, et al. — Circulation, 2023

Tier 2 — Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The American Heart Association updated their guidelines for managing cardiac arrest, respiratory arrest, and refractory shock caused by poisoning, based on structured evidence reviews.

What They Found

The updated guidelines provide recommendations for critical poisoning from 12 categories of substances, including opioids, benzodiazepines, and calcium channel blockers. They also discuss the use of venoarterial extracorporeal membrane oxygenation and over 20 specific antidotes and treatments like naloxone, insulin, and intravenous lipid emulsion.

What This Means for Canadian Patients

These updated guidelines offer healthcare providers comprehensive, evidence-based strategies for treating life-threatening poisoning, potentially improving patient outcomes. Canadian patients experiencing severe poisoning-related emergencies could benefit from healthcare providers adopting these refined treatment protocols.

Canadian Relevance

While this is an American Heart Association guideline with no direct Canadian connection, its evidence-based recommendations are highly relevant and can inform clinical practice for emergency and critical care physicians in Canada.

Study Limitations

As a guideline update, its recommendations are based on existing evidence which may have varying quality or gaps, and clinical applicability can vary based on local resources and patient specifics.

Was this summary helpful?

Study Details

Study Type Clinical Guideline
Category Cardiac
Source Pubmed
PubMed ID 37721023
Year Published 2023
Journal Circulation
MeSH Terms Humans; Adrenergic beta-Antagonists; American Heart Association; Benzodiazepines; Cardiopulmonary Resuscitation; Digoxin; Heart Arrest; United States

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.